Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico

Archives of Osteoporosis

Volumn 8, Issue 1-2, 2013, Pages

  Carlos, Fernando ^a   Clark, Patricia ^b,c   Galindo Suárez, Rosa María ^d   Chico Barba, Laura Gabriela ^b,c  

^a R A C Salud Consultores SA de CV   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d PFIZER INC   (United States)

Author keywords

Costs; Fractures; Mexico; Osteopenia; Osteoporosis

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; FRAGILITY FRACTURE; HEALTH CARE COST; HUMAN; MEDICAL CARE; MEDICAL LITERATURE; MEXICO; OSTEOPENIA; OSTEOPOROSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; CROSS-SECTIONAL STUDY; ECONOMICS; FEMALE; MALE; METABOLIC BONE DISEASE;

ADULT; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MEXICO; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PREVALENCE;

EID: 84875207397     PISSN: 18623522     EISSN: 18623514     Source Type: Journal    
DOI: 10.1007/s11657-013-0125-4     Document Type: Article

References (40)

1. Anonymous (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1-129
2. Keen RW (2003) Burden of osteoporosis and fractures. Curr Osteoporos Rep 1(2):66-70
3. Looker AC, Melton LJ 3rd, Harris TB, Borrud LG, Shepherd JA (2010) Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res 25(1):64-71
4. Lewiecki EM (2008) Prevention and treatment of postmenopausal osteoporosis. Obstet Gynecol Clin North Am 35:301-315
5. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513-521
6. Vestergaard P, Rejnmark L, Mosekilde L (2009) Loss of life years after a hip fracture. Acta Orthop 80:525-530
7. Peasgood T, Herrmann K, Kanis JA, Brazier JE (2009) An updated systematic review of Health State Utility Values for osteoporosis related conditions. Osteoporos Int 20:853-868
8. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726-1733
9. Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3-S7
10. Foundation NO (2008) Clinician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
11. Becker DJ, Kilgore ML, Morrisey MA (2010) The societal burden of osteoporosis. Curr Rheumatol Rep 12:186-191
12. Tarricone R (2006) Cost-of-illness analysis. What room in health economics? Health Policy 77:51-63
13. Clark P, Carlos F, Vazquez-Martinez JL (2010) Epidemiology, costs and burden of osteoporosis in Mexico. Arch Osteoporos 5:9-17
14. Cruz GI, Cisneros DF, Salazar PR, Tejeida LA (2002) Costos institucionales y dificultades en la atención de los pacientes con fracturas por osteoporosis. Acta Ortop Mex 16:292-295
15. Velasco-Murillo V, Navarrete-Hernández E, Pozos-Cavanzo JL, Ojeda-Mijares RI, Camacho-Rodríguez MA (2003) Fracturas en mujeres postmenopáusicas en el IMSS: frecuencia y costos de su atención hospitalaria. Gac Med Mex 139:453-458
16. Clark P, Carlos F, Barrera C, Guzman J, Maetzel A, Lavielle P, Ramirez E, Robinson V, Rodriguez-Cabrera R, Tamayo J, Tugwell P (2008) Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare system. Osteoporos Int 19:269-276
17. Carlos F, Clark P, Maciel H, Tamayo JA (2009) Direct costs of osteoporosis and hip fracture: an analysis for the Mexican Social Insurance Health Care System. Salud Publica Mex 51(suppl 1):S108-S113
18. Consejo Nacional de Población. Proyecciones de la población de México 2005-2050. http://www.conapo.gob.mx/00cifras/5.htm
19. Instituto Nacional de Estadística y Geografía. Encuesta Nacional de Empleo y Seguridad Social (2009) Aguascalientes, Ags. México 2010
20. Kanis JA, on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary health-care level. Technical report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield. University of Sheffield, UK
21. Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV, Task Force of the FRAX Initiative (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:2395-2411
22. Stevenson M, Davis S, Lloyd-Jones M, Beverley C (2007) The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women. Health Technol Assess 11:1-134
23. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033-1046
24. Briggs A, Sculpher M (1998) An introduction to Markov modelling for economic evaluation. PharmacoEconomics 13:397-409
25. Ettinger B, Black DM, Dawson-Hughes B, Pressman AR, Melton LJ 3rd (2010) Updated fracture incidence rates for the US version of FRAX. Osteoporos Int 21:25-33
26. Instituto Mexicano del Seguro Social. Guía de Referencia Rápida (2009) Diagnóstico y Tratamiento de la Osteoporosis en el Adulto. Instituto Mexicano del Seguro Social, Guía de Referencia Rápida, Mexico City
27. Sistema de Protección Social en Salud (2005) Elementos conceptuales, económicos y operativos. En: Unidad de Análisis Económico, Primerath edn. Secretaria de Salud, México, pp 11-38
28. Instituto Mexicano del Seguro Social. Costos Unitarios de Atención Médica. Diario Oficial de la Federación. Martes 18 de mayo de 2010
29. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. Informe Financiero y Actuarial (2010) México, D.F., junio de 2010
30. Instituto Nacional de Rehabilitación (2010) Tabulador de costos de recuperación. Secretaría de Salud, México
31. Instituto Mexicano del Seguro Social (2008) Costos Médico- Técnicos para los Grupos Relacionados con el Diagnóstico (GRD), http://www.imss.gob.mx/profesionales/Documents/GRD-IMSS.pdf
32. Banco de México. Tipo de cambio FIX peso/dólar. http://www.banxico.org.mx/portal-mercado-cambiario/index.html
33. Mueller D, Gandjour A (2009) Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women. Value Health 12:1106-1117
34. Instituto Nacional de Estadística y Geografía. Indicadores de demografía y población. http://www.inegi.org.mx
35. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465-475
36. Shi N, Foley K, Lenhart G, Badamgarav E (2009) Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures. Bone 45(6):1084-1090
37. Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F (2010) Development and use of FRAX in osteoporosis. Osteoporos Int 21(Suppl 2):S407-S413
38. Dilla T, Sacristán JA, Rentero ML (2007) Evaluación económica de teriparatida (forsteo®) en el tratamiento de la osteoporosis posmenopáusica. Rev Esp Econ Salud 6(1):57-64
39. Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. PharmacoEconomics 28(5):395-409
40. Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, Papaioannou A, Bessette L, Brown JP, Goeree R (2012) The burden of illness of osteoporosis in Canada. Osteoporos Int. doi: 10.1007/s00198-012-1931-z